Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2298)
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,634
Price
$35.39
Total Value
$93.22K
Shares Held After
180,597
% of Holdings
1.4%
Cencora, Inc. (COR)
DURCAN DERMOT MARK — Director
Shares
4,000
Price
$274.19
Total Value
$1.10M
Shares Held After
31,767
% of Holdings
12.6%
Cardiff Oncology, Inc. (CRDF)
PACE GARY W — Director
Shares
30,000
Price
$1.22
Total Value
$36.60K
Shares Held After
1,356,376
% of Holdings
2.2%
Cardiff Oncology, Inc. (CRDF)
Mohindru Mani — Director
Shares
24,703
Price
$1.21
Total Value
$29.89K
Shares Held After
24,703
% of Holdings
100.0%
IMMUCELL CORP /DE/ (ICCC)
te Boekhorst Paul Francis Olivier — Director
Shares
8,000
Price
$9.49
Total Value
$75.96K
Shares Held After
17,785
% of Holdings
45.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
37,015
Price
$50.00
Total Value
$1.85M
Shares Held After
521,795
% of Holdings
6.6%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
4,656
Price
$50.00
Total Value
$232.80K
Shares Held After
558,810
% of Holdings
0.8%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$0.96
Total Value
$768.00
Shares Held After
300,566
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
96
Price
$147.11
Total Value
$14.12K
Shares Held After
15,000
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
1,199
Price
$146.24
Total Value
$175.35K
Shares Held After
15,096
% of Holdings
7.4%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
4,861
Price
$145.43
Total Value
$706.96K
Shares Held After
16,295
% of Holdings
23.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
3,748
Price
$144.66
Total Value
$542.19K
Shares Held After
21,156
% of Holdings
15.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
96
Price
$143.90
Total Value
$13.81K
Shares Held After
24,904
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
1,000
Price
$52.50
Total Value
$52.50K
Shares Held After
135,215
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
1,000
Price
$52.50
Total Value
$52.50K
Shares Held After
135,215
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
22,236
Price
$52.50
Total Value
$1.17M
Shares Held After
474,703
% of Holdings
4.5%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
225
Price
$52.51
Total Value
$11.81K
Shares Held After
496,939
% of Holdings
0.0%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
10,000
Price
$53.00
Total Value
$530.00K
Shares Held After
104,395
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
400
Price
$551.74
Total Value
$220.70K
Shares Held After
45,172
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
496
Price
$548.91
Total Value
$272.26K
Shares Held After
45,572
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
881
Price
$547.65
Total Value
$482.48K
Shares Held After
46,068
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
157
Price
$546.15
Total Value
$85.74K
Shares Held After
46,949
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
480
Price
$544.26
Total Value
$261.25K
Shares Held After
47,106
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
160
Price
$541.95
Total Value
$86.71K
Shares Held After
47,586
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
950
Price
$541.25
Total Value
$514.19K
Shares Held After
47,746
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
798
Price
$540.25
Total Value
$431.12K
Shares Held After
48,696
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,305
Price
$539.42
Total Value
$703.94K
Shares Held After
49,494
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
958
Price
$538.03
Total Value
$515.43K
Shares Held After
50,799
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,715
Price
$537.04
Total Value
$921.03K
Shares Held After
51,757
% of Holdings
3.2%
Alignment Healthcare, Inc. (ALHC)
KONOWIECKI JOSEPH S — Director
Shares
25,000
Price
$22.00
Total Value
$550.00K
Shares Held After
1,153,816
% of Holdings
2.1%
WORK Medical Technology Group LTD (WOK)
HRT FINANCIAL LP — 10% Owner
Shares
880,456
Price
$0.05
Total Value
$40.50K
Shares Held After
1,271,912
% of Holdings
69.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,902
Price
$90.38
Total Value
$1.17M
Shares Held After
662,042
% of Holdings
1.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
92,169
Price
$90.38
Total Value
$8.33M
Shares Held After
3,807,660
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,741
Price
$89.98
Total Value
$1.06M
Shares Held After
0
% of Holdings
100.0%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
15
Price
$222.14
Total Value
$3.33K
Shares Held After
18,782
% of Holdings
0.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
301
Price
$221.39
Total Value
$66.64K
Shares Held After
18,797
% of Holdings
1.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
71
Price
$220.46
Total Value
$15.65K
Shares Held After
19,098
% of Holdings
0.4%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
96
Price
$219.13
Total Value
$21.04K
Shares Held After
19,169
% of Holdings
0.5%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
267
Price
$218.18
Total Value
$58.25K
Shares Held After
19,265
% of Holdings
1.4%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
244
Price
$221.46
Total Value
$54.04K
Shares Held After
18,782
% of Holdings
1.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
122
Price
$220.93
Total Value
$26.95K
Shares Held After
19,026
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
128
Price
$219.26
Total Value
$28.06K
Shares Held After
19,148
% of Holdings
0.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
256
Price
$218.14
Total Value
$55.84K
Shares Held After
19,276
% of Holdings
1.3%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
27,695
Price
$0.35
Total Value
$9.69K
Shares Held After
303,719
% of Holdings
8.4%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
389,216
Price
$0.35
Total Value
$136.23K
Shares Held After
4,268,448
% of Holdings
8.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
309
Price
$79.25
Total Value
$24.49K
Shares Held After
105,272
% of Holdings
0.3%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,703
Price
$78.50
Total Value
$133.69K
Shares Held After
105,581
% of Holdings
1.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,850
Price
$79.24
Total Value
$146.59K
Shares Held After
105,272
% of Holdings
1.7%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
6,600
Price
$78.50
Total Value
$518.10K
Shares Held After
107,122
% of Holdings
5.8%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
1,238
Price
$44.75
Total Value
$55.40K
Shares Held After
51,000
% of Holdings
2.4%
Showing 851–900 of 2298 transactions (page 18 of 46)